Former Truck Mechanic Team Freedom, the United States, has developed an exceptional immunity by using the lethal snake poison in their body for five years, including cobra, mumba, retlolnsnack. As a result, scientists have now made the most wide and most effective antivenom in history. This can bring about a revolutionary change in the treatment of snake bites in the future.
Jacob Glanville, chief executive of the US biotech company Centivax and the research paper, said, “The team has been using snake poison to his body for almost five years, which can usually kill a horse. It's wonderful in a single way! '
According to the study, the new antivenom cocktail has been created by combining two protection antibodies and a small molecular poison resistor collected from the blood of the frid. It is capable of full protection in 5 deadly species and partial protection for the rest. Currently conventional antivenum is usually effective against a particular species of poison. And this antibody is usually made of horses or sheep with poison. As a result, there is also the possibility of serious side effects.
When Freed became aware of the risk of collecting snakes in the 21st, he began to poison himself as an antidote. He was in a coma for four days after biting an Egyptian cobra in the 21st, but did not stop. Later he agreed to take the snake on his hand.
The news of this activity came to the notice of Glanville through a YouTube video. It was then that he contacted Freed. In the words of the researcher, 'Freed with the phone – finally! I was waiting for this phone call. '
Although this study is mainly focusing on the poisonous snake of the alpid class, there are plans to create similar antidote against the viper class in the future. In the first phase, the antivenum will be verified by applying snake bite dogs to Australia, then the clinical trial on the human body will begin.
Professor Nicholas Keswell, director of the Snakeboite Research Center in Liverpool School of Tropical Medicine, said: 'This research has unveiled a new horizon. The idea that combinations of minor antibodies can be found – this idea can lead to revolution in future treatment. '
The UK-based news media The Guardian says the research has recently been published in the 'Cell' magazine.
